Prostate Tumor
Showing 1 - 25 of >10,000
Prostate Cancer Trial in Gothenburg (Phytoestrogen-rich foods)
Recruiting
- Prostate Cancer
- Phytoestrogen-rich foods
-
Gothenburg, Västra Götalands Län, SwedenSahlgrenska University Hospital
Jan 18, 2023
Prostatic Tumors, Prostate Cancer, Prostate Adenocarcinoma Trial run by the National Cancer Institute (NCI) (18F-DCFPyL,
Not yet recruiting
- Prostatic Neoplasms
- +2 more
- 18F-DCFPyL
- Stereotactic Body Radiation Therapy
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Feb 2, 2023
Prostate Cancer, Prostatic Tumors Trial in Boston (High-Intensity Interval Training Exercise Program)
Not yet recruiting
- Prostate Cancer
- Prostatic Neoplasms
- High-Intensity Interval Training Exercise Program
-
Boston, Massachusetts
- +1 more
Jun 23, 2023
Prostate Cancer Trial (prostate cancer diagnosis)
Not yet recruiting
- Prostate Cancer
- prostate cancer diagnosis
- (no location specified)
Jul 14, 2023
Prostate Tumor Trial in Seoul (remimazolam, Propofol)
Not yet recruiting
- Prostate Tumor
-
Seoul, Korea, Republic ofYonsei University College of Medicine
Oct 19, 2023
Prospective Androgen Receptor Signaling Inhibitors Resistance
Not yet recruiting
- Prostate Cancer
- +3 more
- (no location specified)
Nov 15, 2023
Tumor Molecular Profiling in Patients With Prostate Cancer
Completed
- Prostate Cancer
- Metastatic Prostate Adenocarcinoma
- Tumor molecular profiling
-
Athens, GreeceHellenic Cooperative Oncology Group
Oct 17, 2022
Prostate Cancer, Prostate Tumor Trial in Winston-Salem (Blood draws, Magnetic resonance imaging (MRI))
Withdrawn
- Prostate Cancer
- Prostate Tumor
- Blood draws
- Magnetic resonance imaging (MRI)
-
Winston-Salem, North CarolinaWake Forest Baptist Comprehensive Cancer Center
Nov 17, 2021
Malignancy Trial in Beijing (Al18F-PSMA-BCH PET/CT)
Recruiting
- Malignancy
- Al18F-PSMA-BCH PET/CT
-
Beijing, Chaoyang, ChinaNational Cancer Center/Cancer Hospital,Chinese Academy of Medica
Mar 7, 2023
Prostate Cancer Trial (Pylarify Piflufolastat Flourine-18 (18F-DCFPyL))
Not yet recruiting
- Prostate Cancer
- Pylarify Piflufolastat Flourine-18 (18F-DCFPyL)
- (no location specified)
Jan 26, 2023
Metastatic Castration Resistant Prostate Cancer Trial in London (IMU-935)
Recruiting
- Metastatic Castration Resistant Prostate Cancer
-
London, United KingdomInstitute of Cancer Research
Jan 31, 2023
Liquid Biopsy Genomic Profiling on Treatment Metastatic Prostate
Recruiting
- Metastatic Prostate Cancer
- Liquid Biopsy
- Archival Tumor DNA sequencing
-
Barcelona, SpainSOLTI Cancer Research Group
May 22, 2023
Metastatic Prostate Cancer, Prostate Cancer, Prostate Tumor Trial run by the NCI (M7824, N-803, MVA-BN-Brachyury)
Recruiting
- Metastatic Prostate Cancer
- +4 more
- M7824
- +4 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 20, 2023
Castration-Resistant Prostate Carcinoma, Prostate Adenocarcinoma Trial in Seattle (Apalutamide, Biopsy, Biospecimen Collection)
Not yet recruiting
- Castration-Resistant Prostate Carcinoma
- Prostate Adenocarcinoma
- Apalutamide
- +6 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Jul 20, 2023
Breast Carcinoma, Endometrial Carcinoma, Prostate Carcinosarcoma Trial in Philadelphia (dietary supplement, other, procedure)
Completed
- Breast Carcinoma
- +2 more
- Dietary Intervention
- +2 more
-
Philadelphia, PennsylvaniaThomas Jefferson University
Jan 4, 2023
Tumor Microenvironment Analysis of Prostate Cancer Metastasis
Recruiting
- Recurrent Prostate Cancer
- Biopsy
-
New York, New YorkColumbia University Medical Center
Mar 22, 2022
Tumor Recurrence Following Radiotherapy
Recruiting
- Prostate Cancer
-
Rochester, MinnesotaMayo Clinic
Jan 20, 2023
Prostate Cancer With Non-invasive Method Based on DNA
Withdrawn
- Prostate Cancer
- +2 more
-
Almaty, KazakhstanKazakh Institute of Oncology and Radiology
Apr 13, 2022
Circulating Tumor Cells in High Risk and Early Metastatic
Recruiting
- High Risk Prostate Carcinoma
- +3 more
- Blood collection
-
Bala-Cynwyd, Pennsylvania
- +1 more
Jun 28, 2022
Prostate Cancer, Prosatatic Tumor Trial run by the National Cancer Institute (NCI) (18F-DCFPyL, Tumor Irradiation, Prostate +
Recruiting
- Prostate Cancer
- Prosatatic Neoplasm
- 18F-DCFPyL
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Apr 7, 2022
Testing Circulating Tumour DNA for Homologous Recombination Gene
Recruiting
- Circulating Tumor DNA
- Metastatic Prostate Cancer
- Blood sample
- Urine sample
-
Tours, FranceUniversity hospital
Sep 6, 2022
Prostate Cancer Trial in New York (huJ591)
Active, not recruiting
- Prostate Cancer
-
New York, New YorkWeill Cornell Medical College
Apr 20, 2022